Faculty profile

Ahmad Haidar

ResearcherEndocrinologyMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Ahmad Haidar

Researcher

Endocrinology

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
26 publications in the last five years, latest in 2026.
Senior (last) author on 16 recent papers, a sign of leading a research group.
Principal investigator on 5 research grants (5 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Type 1 Diabetes Crc Adjunctive Therapy Continuous Subcutaneous Insulin Infusion Insulin Knowledge Dissemination Multiple Daily Injections Patient-Centered Approach

Latest papers

Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.
Diabetes technology & therapeutics · 2026 · senior author
Comparing Automated Lyumjev® Delivery with Carbohydrate Counting, Qualitative Meal-Size Estimation, and Fully Closed-Loop in Type 1 Diabetes: A Pilot, Randomized, Crossover Trial.
Diabetes technology & therapeutics · 2026 · senior author
Author Correction: A Bayesian decision support system for automated insulin doses in adults with type 1 diabetes on multiple daily injections: a randomized controlled trial.
Nature communications · 2026 · senior author

All 63 publications

Latest funding

Café Scientifique: Advances in Type 1 Diabetes
CIHR · 2022 · Nominated PI
$9,788
Canada Research Chair - Tier 2
CIHR · 2020 · Nominated PI
$500,000
Co-administration of pramlintide and insulin via an automated dual-hormone artificial pancreas system to regulate glucose levels in type 1 diabetes: a 4-week, outpatient, randomized, controlled, crossover trial
CIHR · 2019 · Nominated PI
$424,575

All 9 grants and awards

63 publications.

Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.

Sabelli N, Pasqua MR, Perz N, Majdpour D, Tsoukas M, Haidar A

Diabetes technology & therapeutics2026Senior author

DOI: 10.1177/15209156251412812 PMID: 42381172

Comparing Automated Lyumjev® Delivery with Carbohydrate Counting, Qualitative Meal-Size Estimation, and Fully Closed-Loop in Type 1 Diabetes: A Pilot, Randomized, Crossover Trial.

Schumacher C, Tsoukas MA, Legault L, Pasqua MR, Kemp G, Cohen E, Jones R, Dassau E, Haidar A

Diabetes technology & therapeutics2026Senior author

DOI: 10.1177/15209156261456440 PMID: 42267693

Author Correction: A Bayesian decision support system for automated insulin doses in adults with type 1 diabetes on multiple daily injections: a randomized controlled trial.

Kobayati A, El Fathi A, Garfield N, Legault L, Jafar A, Yale JF, Tsoukas MA, Haidar A

Nature communications2026Senior author

DOI: 10.1038/s41467-026-72173-6 PMID: 41997984

Semaglutide and cardiovascular risk in type 1 diabetes: A predictive modelling analysis in a double-blind, randomised, placebo-controlled cross-over trial.

Kugathasan L, Tsoukas MA, Nardone M, Sridhar VS, Muskiet MHA, Cherney DZI, Haidar A, Pasqua MR

Diabetes, obesity & metabolism2026

DOI: 10.1111/dom.70525 PMID: 41623193

Inter- and intra-physician variability in insulin injection adjustments compared with Bayesian algorithm recommendations in type 1 diabetes.

Kobayati A, Tsoukas MA, Garfield N, Legault L, Pasqua MR, Yale JF, Meltzer SJ, Wing SS, Michaud S, Tardio V, Peters T, Bond R, Krishnamoorthy P, Fantus IG, Rutkowski J, El Fathi A, Ngo A, Lovblom LE, Haidar A

Diabetologia2026Senior author

DOI: 10.1007/s00125-025-06627-9 PMID: 41396299

Continuous Ketone Monitoring Captures Overt Ketosis in Type 1 Diabetes Caused by Empagliflozin, Low-Carbohydrate Diet, and Exercise.

Lawton E, Perz L, Pasqua MR, Tsoukas M, Haidar A

Diabetes technology & therapeutics2026Senior author

DOI: 10.1177/15209156261420167 PMID: 41640091

Semaglutide Use With Automated Insulin Delivery in Adults With Type 1 Diabetes: Qualitative Analyses and Patient-reported Outcomes From a Randomized Controlled Trial.

Pasqua MR, Doumat J, Tsoukas MA, Haidar A

Canadian journal of diabetes2026Senior author

DOI: 10.1016/j.jcjd.2025.10.175 PMID: 41175929

Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology.

Dhatariya K, Bergenstal RM, Al-Sofiani M, Albanese-O'Neill A, Battelino T, Close K, De Block C, Dutta S, Galindo RJ, GhavamiNejad A, Haidar A, Heverly J, Kruger D, Laffel LM, Lally J, Maahs DM, Maffeis C, Mathieu C, Miller E, Munshi M, Nishimura R, Nørgaard K, Oron T, O'Neal DN, Oxenreiter M, Perkins BA, Phillip M, Renard E, Rosen J, Scharf M, Sherr J, Wysham C, Danne T

The lancet. Diabetes & endocrinology2026

DOI: 10.1016/s2213-8587(25)00331-6 PMID: 41381175

Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post-hoc analysis of a double-blinded, randomised, crossover trial.

Pasqua MR, Tsoukas MA, Haidar A

Diabetes, obesity & metabolism2026Senior author

DOI: 10.1111/dom.70213 PMID: 41144928

Semaglutide withdrawal in adults with type 1 diabetes on pump therapy: A post-hoc analysis from a double-blinded randomized controlled trial.

Pasqua MR, Tsoukas MA, Haidar A

Diabetes, obesity & metabolism2026Senior author

DOI: 10.1111/dom.70185 PMID: 41063383

Something wrong or missing on this profile? Suggest a correction

Ahmad Haidar

Research

Latest papers

Latest funding

Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.

Comparing Automated Lyumjev® Delivery with Carbohydrate Counting, Qualitative Meal-Size Estimation, and Fully Closed-Loop in Type 1 Diabetes: A Pilot, Randomized, Crossover Trial.

Author Correction: A Bayesian decision support system for automated insulin doses in adults with type 1 diabetes on multiple daily injections: a randomized controlled trial.

Semaglutide and cardiovascular risk in type 1 diabetes: A predictive modelling analysis in a double-blind, randomised, placebo-controlled cross-over trial.

Inter- and intra-physician variability in insulin injection adjustments compared with Bayesian algorithm recommendations in type 1 diabetes.

Continuous Ketone Monitoring Captures Overt Ketosis in Type 1 Diabetes Caused by Empagliflozin, Low-Carbohydrate Diet, and Exercise.

Semaglutide Use With Automated Insulin Delivery in Adults With Type 1 Diabetes: Qualitative Analyses and Patient-reported Outcomes From a Randomized Controlled Trial.

Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology.

Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post-hoc analysis of a double-blinded, randomised, crossover trial.

Semaglutide withdrawal in adults with type 1 diabetes on pump therapy: A post-hoc analysis from a double-blinded randomized controlled trial.

Café Scientifique: Advances in Type 1 Diabetes

Canada Research Chair - Tier 2

Co-administration of pramlintide and insulin via an automated dual-hormone artificial pancreas system to regulate glucose levels in type 1 diabetes: a 4-week, outpatient, randomized, controlled, crossover trial

CREATE: Industry-Ready talent for Canadian MedTech

Cafe Scientific: Practical Tips for Glucose Management and Advances in Type 1 Diabetes Research

Automated closed-loop control of glucose levels in type 1 diabetes patients with hypoglycemia unawareness

CRC Tier 2

Developing and clinically testing a learning algorithm that optimizes the performance of the artificial pancreas

Closed-loop regulation of glucose levels in patients with type 1 diabetes

Frequent collaborators

Laurent Legault

Laurent Legault

Michael Tsoukas

Rémi Rabasa-Lhoret

Jean-Louis Chiasson

Robert Kearney

Rémi Rabasa-Lhoret

Tricia Peters

Alanna Weisman

Nadine Taleb

Ahmad Haidar

Research

Latest papers

Latest funding

Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.

Comparing Automated Lyumjev&#xae; Delivery with Carbohydrate Counting, Qualitative Meal-Size Estimation, and Fully Closed-Loop in Type 1 Diabetes: A Pilot, Randomized, Crossover Trial.

Author Correction: A Bayesian decision support system for automated insulin doses in adults with type 1 diabetes on multiple daily injections: a randomized controlled trial.

Semaglutide and cardiovascular risk in type 1 diabetes: A predictive modelling analysis in a double-blind, randomised, placebo-controlled cross-over trial.

Inter- and intra-physician variability in insulin injection adjustments compared with Bayesian algorithm recommendations in type 1 diabetes.

Continuous Ketone Monitoring Captures Overt Ketosis in Type 1 Diabetes Caused by Empagliflozin, Low-Carbohydrate Diet, and Exercise.

Semaglutide Use With Automated Insulin Delivery in Adults With Type 1 Diabetes: Qualitative Analyses and Patient-reported Outcomes From a Randomized Controlled Trial.

Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology.

Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post-hoc analysis of a double-blinded, randomised, crossover trial.

Semaglutide withdrawal in adults with type 1 diabetes on pump therapy: A post-hoc analysis from a double-blinded randomized controlled trial.

CREATE: Industry-Ready talent for Canadian MedTech

Frequent collaborators

Laurent Legault

Laurent Legault

Michael Tsoukas

Rémi Rabasa-Lhoret

Jean-Louis Chiasson

Robert Kearney

Rémi Rabasa-Lhoret

Tricia Peters

Alanna Weisman

Nadine Taleb

Comparing Automated Lyumjev® Delivery with Carbohydrate Counting, Qualitative Meal-Size Estimation, and Fully Closed-Loop in Type 1 Diabetes: A Pilot, Randomized, Crossover Trial.